Becton Dickinson Return on Tangible Equity 2010-2023 | BDX

Current and historical return on tangible equity values for Becton Dickinson (BDX) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Becton Dickinson Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2023-12-31 $1.22B $-9.88B -12.10%
2023-09-30 $1.42B $-9.67B -13.67%
2023-06-30 $1.58B $-9.96B -14.49%
2023-03-31 $1.53B $-10.77B -13.86%
2022-12-31 $1.52B $-11.28B -13.47%
2022-09-30 $1.69B $-11.65B -14.56%
2022-06-30 $1.67B $-10.36B -13.96%
2022-03-31 $1.83B $-11.84B -14.62%
2021-12-31 $1.68B $-12.57B -13.30%
2021-09-30 $2.00B $-12.98B -15.86%
2021-06-30 $1.87B $-12.68B -14.57%
2021-03-31 $1.64B $-12.19B -12.58%
2020-12-31 $1.51B $-12.65B -10.62%
2020-09-30 $0.77B $-13.67B -5.02%
2020-06-30 $0.79B $-13.64B -4.87%
2020-03-31 $0.92B $-16.84B -5.40%
2019-12-31 $0.76B $-16.96B -4.38%
2019-09-30 $1.08B $-17.27B -6.12%
2019-06-30 $0.78B $-17.34B -4.33%
2019-03-31 $0.93B $-17.91B -5.02%
2018-12-31 $0.90B $-18.16B -4.75%
2018-09-30 $0.16B $-19.05B -0.82%
2018-06-30 $0.62B $-18.79B -4.23%
2018-03-31 $-0.10B $-19.34B 0.98%
2017-12-31 $0.29B $-20.13B -4.35%
2017-09-30 $1.03B $-0.51B -32.15%
2017-06-30 $0.76B $-0.91B -16.55%
2017-03-31 $1.32B $-5.48B -22.62%
2016-12-31 $1.31B $-5.91B -21.74%
2016-09-30 $0.98B $-6.07B -15.50%
2016-06-30 $1.14B $-5.80B -17.16%
2016-03-31 $0.81B $-6.31B -11.55%
2015-12-31 $0.69B $-7.02B -9.23%
2015-09-30 $0.70B $-7.40B -14.12%
2015-06-30 $0.82B $-7.34B -35.88%
2015-03-31 $1.08B $-8.06B 251.37%
2014-12-31 $1.15B $3.11B 34.99%
2014-09-30 $1.19B $3.20B 35.90%
2014-06-30 $0.97B $3.47B 29.74%
2014-03-31 $0.95B $3.37B 30.60%
2013-12-31 $0.94B $3.16B 32.18%
2013-09-30 $1.29B $3.10B 46.99%
2013-06-30 $1.49B $2.78B 58.77%
2013-03-31 $1.52B $2.63B 61.79%
2012-12-31 $1.53B $2.50B 62.30%
2012-09-30 $1.17B $2.25B 45.50%
2012-06-30 $1.18B $2.45B 42.65%
2012-03-31 $1.20B $2.64B 38.66%
2011-12-31 $1.22B $2.95B 36.65%
2011-09-30 $1.27B $3.04B 36.50%
2011-06-30 $1.37B $3.76B 36.43%
2011-03-31 $1.33B $3.55B 35.23%
2010-12-31 $1.32B $3.58B 34.24%
2010-09-30 $1.32B $4.13B 33.50%
2010-06-30 $1.24B $3.86B 31.50%
2010-03-31 $1.27B $3.82B 31.69%
2009-12-31 $1.24B $3.92B 30.82%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $69.527B $19.372B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $66.590B 17.82
West Pharmaceutical Services (WST) United States $25.910B 43.34
Cardinal Health (CAH) United States $25.629B 15.40
Align Technology (ALGN) United States $24.013B 47.58
Cooper (COO) United States $19.020B 29.91
Labcorp (LH) United States $18.310B 15.49
Henry Schein (HSIC) United States $9.829B 14.98
DENTSPLY SIRONA (XRAY) United States $7.150B 18.24
Merit Medical Systems (MMSI) United States $4.617B 26.74
Patterson (PDCO) United States $2.632B 12.03
CONMED (CNMD) United States $2.500B 23.56
STAAR Surgical (STAA) United States $1.503B 68.42
Atrion (ATRI) United States $0.627B 29.47
Lifevantage (LFVN) United States $0.089B 14.42
Pro-Dex (PDEX) United States $0.061B 23.32
Biolase (BIOL) United States $0.001B 0.00